hisential logo

Weight Management at Hisential Singapore: Advanced Therapies + Sustainable Lifestyle Change

Obesity and overweight affect increasing numbers of people worldwide, and Singapore is no exception. At Hisential Singapore, our weight-management programme combines cutting-edge injectable therapies, personalised nutrition and lifestyle guidance, and ongoing medical supervision. Whether you have a body mass index (BMI) above the recommended range or struggle with weight despite diet and exercise, we aim to give you safe, effective options tailored to your needs.

Enquire via WhatsApp

What are GLP-1 Injections and How They Help 

The class of medications known as GLP-1 (glucagon-like peptide-1) receptor-agonists were originally developed for type 2 diabetes treatment. They work by mimicking the GLP-1 hormone, which is released in the gut after food, and which reduces appetite, slows gastric emptying and helps regulate blood sugar. Over recent years, these therapies have been adapted and approved for weight management in people without diabetes as well. 

At Hisential we offer supervised use of these injectable therapies as part of a comprehensive weight-management plan. However, they are not a magic bullet: success still depends on lifestyle change, nutrition, physical activity and regular follow-up. 

The Evolution of GLP-1 Therapies

From first to third generation: how GLP-1 treatments have advanced
First-Gen
Older diabetes drugs with short-acting GLP-1 mechanisms
Description
Early versions used for diabetes that helped control blood sugar for short periods.
Effect
Mild weight loss and required daily injections.
Second-Gen
Long-acting, once-weekly mono-agonists
Description
Updated versions that last longer and only need weekly doses.
Effect
Helped many people lose around 7–8 kg over a year when combined with lifestyle change.
Third-Gen
Dual or tri-agonist therapies (GLP-1 + GIP ± glucagon)
Description
Newer treatments that act on multiple hormones to boost results.
Effect
Can achieve up to 20% body weight reduction in some individuals.
Clinical takeaway: each generation improves appetite control and metabolism. The best results come when treatment is combined with good nutrition, regular activity, and ongoing support.
For supervised use and suitability, speak with a Hisential Doctor.

Second-Generation vs Third-Generation Injectable Therapies 

In the evolution of GLP-1 therapies for weight loss, we can loosely categorise “second-generation” versus emerging “third-generation” treatments (or dual/tri-agonist therapies) to help explain how the field is advancing. 

Second-Generation Injectables 

These newer GLP-1 receptor agonists (long-acting, once-weekly or similar) showed substantial weight-loss benefits compared to older first-generation diabetes drugs. For example, meta-analyses found that GLP-1 receptor agonists could reduce body weight by around 7.0 kg at 52 weeks in trials of mono-agonists. Another systematic review reported mean weight-loss reductions of about −8.47 kg with some of the more potent second-generation agents in people with type 2 diabetes. These therapies improved metabolic parameters, satiety, and reduced appetite in many individuals. 

Third-Generation / Dual- or Tri-Agonist Therapies 

The next wave of therapies build on the GLP-1 receptor mechanism by also targeting additional hormones (for example, GIP, glucagon or other pathways). Evidence suggests significantly greater weight-loss in many cases. A recent model-based meta-analysis found that, for example, tri-agonists had mean weight-reduction effects of up to around −22.6 kg at 52 weeks in obesity trials. In addition, a review noted that certain combined-agonist therapies achieved weight-loss beyond what the earlier GLP-1 mono-agonists could.  

What this means clinically 

In practical terms: second-generation therapies are highly useful and have established safety and efficacy. They may help many individuals achieve significant weight-loss (for example, in the range of 10-15% of body weight when combined with lifestyle change). Third-generation or dual/tri-agonist therapies offer the potential for greater weight-loss, potentially reaching 20% or more of body-weight reduction in selected individuals. At Hisential we assess each patient for suitability based on their medical history, weight loss goals, and willingness to commit to lifestyle change. 

We emphasise: whichever injectable is used, it is most effective when combined with nutrition, exercise, behavioural support and ongoing follow-up. 

 

Role of Nutrition, Lifestyle and Behaviour Change 

Injection therapy alone cannot sustain long-term weight management without lifestyle support. At Hisential Singapore, we integrate the following: 

  • Personalised nutrition plan: based on your baseline weight, metabolic profile, food preferences and any medical conditions (e.g., diabetes, thyroid issues). We emphasise whole foods, adequate protein, fibre-rich vegetables, healthy fats and controlled carbohydrates. 
  • Physical activity prescription: a mixture of aerobic, resistance and mobility training, tailored to your ability and starting level. Building lean muscle helps boost metabolism and improve body composition beyond just the scale. 
  • Behavioural support and habit formation: learning mindful eating, managing emotional triggers for overeating, improving sleep hygiene, reducing stress and building sustainable habits rather than quick fixes. 
  • Medical monitoring: regular follow-up visits to assess progress (weight, waist circumference, metabolic markers), adjust therapeutic dose if using injectables, and ensure safety. 

When injection therapy is combined with these lifestyle fundamentals, outcomes are markedly better with more weight loss, better health markers and greater likelihood of maintaining results long term. 

Why Early & Sustained Intervention Matters 

Obesity isn’t just about the number on the scale — it heightens your risk of type 2 diabetes, heart disease, certain cancers and joint problems. By intervening early with a comprehensive programme (rather than just diet “yo-yo”), you increase your chances of preserving lean muscle, improving metabolic health, lowering blood pressure and improving quality of life. 

Moreover, newer therapies mean you don’t have to wait years for results; the combination of injectables plus structured lifestyle support means you can see meaningful improvement within 3-6 months while still building sustainable habits for maintenance. 

Who is a Candidate at Hisential Singapore? 

We consider injectable therapies for weight management in patients who: 

  • Have a BMI in the overweight or obese range (e.g., ≥27.5 kg/m² for Asians) and one or more weight-related health risks (hypertension, sleep apnoea, diabetes, dyslipidaemia); or 
  • Have tried lifestyle change alone for a defined period (e.g., 6-12 months) without sufficient weight loss; and 
  • Are motivated to engage with the lifestyle programme (nutrition, activity, follow-up) and understand the commitment involved. 

We do not recommend injectables alone without lifestyle change; nor are they appropriate for everyone (contraindications include certain thyroid, pancreatic or gastrointestinal conditions, pregnancy, or uncontrolled psychiatric illness). Our medical team assesses suitability on a case-by-case basis. 

 
Phase
Duration
Purpose
Key Focus
Initiation
Duration4–8 weeks
PurposeDose adjustment & tolerance
Key FocusGradual titration
Therapeutic
Duration3–6 months
PurposeActive fat loss
Key FocusLifestyle integration
Stabilisation
Duration3+ months
PurposeWeight maintenance
Key FocusHabit reinforcement

Frequently Asked Questions About GLP-1 & Weight Loss Management

Frequently Asked Questions About GLP-1 & Weight Loss Management

Many patients begin to see measurable weight-loss within the first 4–12 weeks, with meaningful results by 3–6 months. Long-term trials show continued weight-loss up to 52 weeks when combined with lifestyle changes. Results vary by individual.

Second-generation injections are GLP-1 mono-agonists with strong evidence for weight management. Third-generation (dual/tri-agonist) therapies target multiple hormonal pathways and may lead to greater weight-loss but often at higher cost.

Weight regain can occur if lifestyle habits are not maintained. This is why therapy is combined with nutrition, activity, and habit-building to help sustain results even after stopping medication.

Common side-effects include nausea, vomiting, constipation, or diarrhoea, especially when starting or increasing dosage. Rare risks include gall-bladder issues or pancreatitis. Patients are monitored closely.

Absolutely. The injection supports appetite control but does not replace healthy eating, physical activity, and behaviour change. Best results come from combining all.

Duration varies by individual goals and response. Some patients use it for 12–24 months, others longer if clinically indicated, with regular medical review.

No. It is not suitable for pregnancy, certain thyroid conditions, severe GI disease, or other contraindications. A full medical assessment is required before starting.

References

Why Choose Hisential

At Hisential, men’s health is our specialty. We don’t just provide treatment. We provide confidence, discretion, and expertise. Our goal is to give you an experience with no crowded waiting rooms. No rushed consults. Just clinical excellence, delivered with absolute discretion in a space designed to make you feel respected and in control.

Take The First Step

If you are ready to reclaim your health, enhance your quality of life and achieve sustainable weight-loss, Hisential Singapore is here to support you every step of the way. Our medical staff will walk you through a comprehensive consultation, discuss whether injectable therapy + lifestyle programme is suitable for you, and help you craft a personalised plan that fits your lifestyle and goals.
Whatsapp
Phone
Email

Hisential Orchard Clinic
#04-13, Mandarin Gallery,
333A Orchard Road, 238897 Singapore
Open in Google Maps | Call Us +65-3125 6028 | Whatsapp +65 8963 5233

©Copyright 2026 - Hisential® - All rights reserved